Listed

ENDRA Life Sciences Inc.: Form 8-K, filed Jun 2, 2017

Filed with the SEC on Jun 2, 2017 and accepted by EDGAR at Jun 2, 2017, 06:02 ET.

Share

Items reported

  • Item 7.01 Regulation FD disclosure
  • Item 9.01 Financial statements and exhibits

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001654954-17-005285. Last ingested by Listed: Nov 10, 2026, 17:03 ET. Listed shows no prices and gives no investment advice.